Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Guardian Pharmacy Services (GRDN) Income towards Parent Company (2023 - 2025)

Guardian Pharmacy Services (GRDN) has disclosed Income towards Parent Company for 3 consecutive years, with $21.3 million as the latest value for Q4 2025.

  • Quarterly Income towards Parent Company rose 79.59% to $21.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $49.0 million through Dec 2025, up 168.92% year-over-year, with the annual reading at $49.0 million for FY2025, 168.92% up from the prior year.
  • Income towards Parent Company hit $21.3 million in Q4 2025 for Guardian Pharmacy Services, up from $9.6 million in the prior quarter.
  • In the past five years, Income towards Parent Company ranged from a high of $21.3 million in Q4 2025 to a low of -$105.8 million in Q3 2024.
  • Historically, Income towards Parent Company has averaged -$1.5 million across 3 years, with a median of $9.4 million in 2025.
  • Biggest five-year swings in Income towards Parent Company: tumbled 1412.75% in 2024 and later surged 109.07% in 2025.
  • Year by year, Income towards Parent Company stood at $14.6 million in 2023, then dropped by 18.67% to $11.8 million in 2024, then soared by 79.59% to $21.3 million in 2025.
  • Business Quant data shows Income towards Parent Company for GRDN at $21.3 million in Q4 2025, $9.6 million in Q3 2025, and $8.8 million in Q2 2025.